Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

2020339 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 397, Issue 10268, pp. 51-60

Field-Weighted Citation Impact: 26.05